XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements Of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Sales $ 16,672,416 $ 14,626,904 $ 46,534,358 $ 42,462,265
Cost of Sales 14,703,606 13,555,853 49,303,048 37,535,454
Gross Profit (Loss) 1,968,810 1,071,051 (2,768,690) 4,926,811
Selling, General and Administrative 6,159,141 4,791,636 15,182,048 17,433,530
Settlement Expense, net of Reimbursement     1,030,000  
Research and Product Development 808,192 1,304,658 4,033,494 4,195,003
Operating Loss (4,998,523) (5,025,243) (23,014,232) (16,701,722)
Interest and Investment Income (Loss) (4,969,632) (5,056,994) (22,749,945) (16,882,001)
Net Loss $ 28,891 $ (31,751) $ 264,287 $ (180,279)
Basic and Diluted Net Loss per Share $ (0.10) $ (0.10) $ (0.44) $ (0.33)
Basic and Diluted Weighted Average Shares Outstanding (in shares) 51,288,537 51,260,975 51,288,462 50,995,079